KOD

NASD Kodiak Sciences, Inc.
Oct 2, 2026 · 2:41 AM ET EOD Market Closed

$98.46 ↑ +0.00 (+0.00%) Trading Up from the previous close of $98.46, $5.54 below the day’s high of $104.00

YTD change
+252.15%
vs 20-day SMA
+132.37%
vs 200-day SMA
+182.12%

Price ranges

Previous day
$88.48 $98.80
open $93.83 close $94.80
+$0.97 (+1.03%)
Today
$93.95 $104.00
open $95.41 now $98.46
+$3.05 (+3.20%)
Past week
$29.81 $98.80
from $31.52 now $98.46
+$66.94 (+212.37%)
Past month
$29.81 $98.80
from $37.06 now $98.46
+$61.40 (+165.68%)
This year
$20.88 $104.00
from $27.96 now $98.46
+$70.50 (+252.15%)

Price & Performance

+55.65 (+129.99%) / 6M

$24.10$50.72$77.35$103.97Apr 1Jul 2Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 42.5% away from all-time highs of $171.21
  • KOD is up 252% since the beginning of the year
  • KOD is up 525% over the past 12 months
  • KOD is up 166% over the past 1 month
  • 52% of all KOD investors are betting against KOD

KOD reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +524.7%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.05
Earnings momentum +1.2% Quarterly EPS growth
Quarterly change +1.2%

Valuation

P/E ratio N/A
Enterprise value $6.0B
Beta 2.13

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$125.9M
Debt$152.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $6.2B

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.27 -3.38%
MRNA Moderna, Inc. $188.94 -1.89%
RVMD Revolution Medicines, Inc. $205.89 +0.31%
ROIV Roivant Sciences Ltd. $35.50 -2.93%
BNTX BioNTech SE Sponsored ADR $96.85 -1.48%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.